Interaction of neuroactive drugs and group-specific ligands with purified human serum cholinesterase.
Marquis
J K
JK
D001665:Binding Sites; D002091:Butyrylcholinesterase / Q000097:blood* / Q000302:isolation & purification; D002243:Carbolines / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D002800:Cholinesterase Inhibitors; D002802:Cholinesterases / Q000097:blood*; D006635:Histamine H2 Antagonists / Q000494:pharmacology; D006801:Humans; D008154:Lucanthone / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D014268:Trifluoperazine / Q000494:pharmacology
D002243:Carbolines; D002800:Cholinesterase Inhibitors; D006635:Histamine H2 Antagonists; D010276:Parasympatholytics; D014268:Trifluoperazine; D002091:Butyrylcholinesterase; D002802:Cholinesterases; D008154:Lucanthone